Keeping on schedule

tug of war vector
No change to Symbicort scheduling, TGA confirms, however an antihistamine will move to Schedule 3 The TGA has confirmed a previous interim decision to reject the downscheduling of the asthma treatment budesonisde-formoterol (Symbicort). This proposal was to move budesonide and formoterol from Schedule 4 to Schedule 3 when combined in an inhaler, for "use as

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Pharmacists crucial to ICU follow-up
Next Clinical Tips: Tonsillitis